Aroa BiosurgeryAROAF +35.24%39 Days Inventory is 157.85 as of Mar. 2026, which is 20% below its 10-year median of 196.48. GuruFocus rates AROAF with a GF Score™ of 39/100 and a GF Value™ of $0.71 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 787 Medical Devices & Instruments companies, Aroa Biosurgery ranks worse than 54.38% on this metric.
The historical rank and industry rank for Aroa Biosurgery's Days Inventory or its related term are showing as below:
AROAF'
s Days Inventory Range Over the Past 10 Years
Min: 146.82 Med: 196.48 Max: 248.47
Current: 190.58
During the past 7 years, Aroa Biosurgery's highest Days Inventory was 248.47. The lowest was 146.82. And the median was 196.48.
AROAF's Days Inventory is ranked worse than 54.38% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.73
vs AROAF: 190.58
Aroa Biosurgery's Days Inventory
declined
from Mar. 2025 (243.31) to Mar. 2026 (157.85).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Aroa Biosurgery's Inventory Turnover for the
six
months ended in Mar. 2026 was 1.16.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aroa Biosurgery's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.12.
Aroa Biosurgery (OTCPK:AROAF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Aroa Biosurgery's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aroa Biosurgery's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Aroa Biosurgery Days Inventory Related Terms
Aroa Biosurgery Days Inventory Historical Data
* Premium members only.
The historical data trend for Aroa Biosurgery's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Aroa Biosurgery's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aroa Biosurgery Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aroa Biosurgery's Days Inventory distribution charts can be found below:
* The bar in red indicates where Aroa Biosurgery's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aroa Biosurgery (AROAF) has a Days Inventory of 157.85 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aroa Biosurgery and its competitors. This is 20% below median its historical median of 196.48. Over the past decade, Aroa Biosurgery's Days Inventory has ranged from 146.82 to 248.47. According to the industry distribution chart, Aroa Biosurgery ranks #428 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 54.4%.
Is Aroa Biosurgery's Days Inventory too high?
Aroa Biosurgery's current Days Inventory of 157.85 is 20% below median its 10-year median of 196.48. Over the past 10 years, this metric has ranged from a low of 146.82 to a high of 248.47. The Medical Devices & Instruments industry median Days Inventory is 179.73. Aroa Biosurgery's value of 157.85 is 12.2% below this industry median. Based on the distribution chart, Aroa Biosurgery ranks #428 out of 787 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Aroa Biosurgery has a GF Score™ of 39/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aroa Biosurgery's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aroa Biosurgery ranks #428 out of 787 companies for Days Inventory. This places Aroa Biosurgery in the lower half of its industry. The industry median Days Inventory is 179.73. Aroa Biosurgery's value of 157.85 is 12.2% below this benchmark. Historically, Aroa Biosurgery's own Days Inventory has ranged from 146.82 to 248.47 over the past decade. While the company's 10-year median is 196.48 vs. the industry median of 179.73, Aroa Biosurgery has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.73, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aroa Biosurgery's current Days Inventory of 157.85 is 12.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aroa Biosurgery and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aroa Biosurgery's current Days Inventory is 157.85, which is 20% below median its own 10-year median of 196.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aroa Biosurgery stock overvalued right now?
Based on GuruFocus' analysis, Aroa Biosurgery (AROAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.71, compared to a current price of $0.52 — trading 26.8% below its estimated fair value. The current Days Inventory is 157.85, which is 20% below median its 10-year median of 196.48 and 12.2% below the Medical Devices & Instruments industry median of 179.73. Aroa Biosurgery's overall GF Score™ is 39/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Aroa Biosurgery (AROAF), the current Days Inventory is 157.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aroa Biosurgery (AROAF) Overvalued in 2026?
Based on GuruFocus' analysis, Aroa Biosurgery stock appears to be undervalued.
The current stock price of $0.52 is trading 26.8% below its estimated GF Value™ of $0.71.
GuruFocus considers Aroa Biosurgery to be Modestly Undervalued.
Key valuation signals for AROAF:
Days Inventory: 157.85 (20% below median its 10-year median of 196.48)
GF Value™: $0.71 vs. price of $0.52 (26.8% below fair value)
Industry Position: 12.2% below the Medical Devices & Instruments median (#428 of 787)
No single metric tells the full story. See the AROAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aroa Biosurgery Ltd is a soft tissue regeneration company that develops, manufactures, and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The company is in the business of developing, manufacturing, and selling soft tissue repair products. The company's principal market is the United States, where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery, and trauma/limb salvage/tumor surgery.
39GF Score
Get the complete analysis for AROAF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AROAF has been successfully added to your 
